FDA Clearance Tracker · P160015-S029
AED 3 Defibrillator with Uni-Padz
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Oct 16, 2026
Approved
Time to decision
28 days
Received Sep 18, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160015-S029
- Device name
- AED 3 Defibrillator with Uni-Padz
- Applicant
- ZOLL Medical Corporation
- Applicant location
- Chelsmford, MA
- Received
- Sep 18, 2026
- Decided
- Oct 16, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P160015
Device type
- Device class
- Class III
- Regulation
- 21 CFR 870.5310
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval of the protocol for the post-approval study (PAS) referenced above to replace the original PAS protocol. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.
Source documents
Other decisions for ZOLL Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- 731 Series Ventilator510(k)
K233486 · Decided Dec 13, 2024 · 413 days after receipt
Device type: Ventilator, Continuous, Facility Use (CBK) · Anesthesiology & Respiratory
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.